Skip to main content
. 2020 Nov 4;10:578763. doi: 10.3389/fonc.2020.578763

Figure 1.

Figure 1

Kaplan–Meier overall survival (OS) rate curves for patients underwent TACE+LR and LR for BCLC stage B hepatocellular carcinoma (HCC) before and after PSM, January 2007 to December 2015. (A) the OS rate of patients before PSM, (B) the OS rate of patients after PSM. OS rates of the patients who received TACE+LR were significantly higher than OS rates of those who received only LR both before and after PSM (P < 0.001).